Holen Sie sich die Stockscreener-App
26.19
2.96%
-0.80
Handel nachbörslich:
25.68
-0.51
-1.95%
Finanzdaten der Mineralys Therapeutics Inc-Aktie (MLYS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
12.01%
41.13
|
46.75 | 44.45 | 60.11 | 45.17 |
| Operating Income/Loss |
12.01%
-41.13
|
-46.75 | -44.45 | -60.11 | -45.17 |
| Nonoperating Income/Loss |
20.94%
4.199
|
3.472 | 2.236 | 3.764 | 4.154 |
| Income/Loss From Continuing Operations Before Tax |
14.66%
-36.93
|
-43.27 | -42.21 | -56.34 | -41.01 |
| Income/Loss From Continuing Operations After Tax |
14.66%
-36.93
|
-43.27 | -42.21 | -56.34 | -41.01 |
|
Net Income/Loss
|
14.66%
-36.93
|
-43.27 | -42.21 | -56.34 | -41.01 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7.86%
70.59
|
65.45 | 53.16 | 49.82 | 49.36 |
| Diluted Average Shares |
7.86%
70.59
|
65.45 | 53.16 | 49.82 | 49.36 |
| Basic Earnings Per Share |
21.21%
-0.52
|
-0.66 | -0.79 | -1.13 | -0.83 |
| Diluted Earnings Per Share |
21.21%
-0.52
|
-0.66 | -0.79 | -1.13 | -0.83 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):